Trials / Not Yet Recruiting
Not Yet RecruitingNCT06040476
Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS)
A Phase II, Randomized, Double-blind, Parallel, Placebo-controlled Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 39 (estimated)
- Sponsor
- StemCyte, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A Phase II, Randomized, Double-blind, Parallel, Placebo-controlled Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke
Detailed description
This is a phase II study to evaluate the safety and efficacy in hUCB treatment on the patients with acute ischemic stroke (AIS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | hUCB | hUCB |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2027-12-01
- Completion
- 2028-08-01
- First posted
- 2023-09-15
- Last updated
- 2025-02-27
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06040476. Inclusion in this directory is not an endorsement.